Twitter starts to catch on in biotech

In the biotech arena, some people have become well-known by their Twitter handles that include the "@" symbol and some combination of numbers, letters and characters. Xconomy's Luke Timmerman (@ldtimmerman) chronicled some recent Twitter action and trends in the biotech scene in his latest column. The upshot: Twitter apparently isn't a flash in the pan for communication among biotech professionals. The social networking platform has become a lively forum for debating ideas and sharing news and insights in life sciences. Richard Pops (@popsalks), the chairman and CEO of the biopharma group Alkermes ($ALKS), told Timmerman: "Twitter = New Frontier. Someone has to lead." Column

Suggested Articles

Trialbee has added ex-Lundbeck CEO Ulf Wiinberg and former Bristol-Myers Squibb SVP Lars Birgerson to its board of directors.

Researchers have enrolled 2,000 people with metastatic breast cancer in 7 months using a social media-enabled, direct-to-patient model of recruiting.

Medisafe has started pitching an app and services to increase medication adherence and facilitate patient recruitment to biopharma companies.